X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Josephine Martin

Josephine Martin Josie Martin is Executive Vice President of Public Affairs at PhRMA. In a career spanning over 20 years, she worked on the Senate Finance Committee, The American Red Cross and has touched many facets of healthcare communications, from anti-smoking campaigns and getting America fit to cancer awareness.

Recent Posts

Fighting blood cancers together at the 2016 Leukemia Ball

By Josephine Martin  |    March 11, 2016
Tomorrow, the Leukemia & Lymphoma Society (LLS) will hold one of Washington, D.C.’s largest charitable events: the 2016 Leukemia Ball. Since it began in 1988, the annual event has raised nearly...   Read More

Tune in now to the PhRMA 2016 Annual Meeting

By Josephine Martin  |    March 9, 2016
Today at 4:00 p.m. will mark the start of the PhRMA 2016 Annual Meeting here in Washington, D.C. Click below to watch events so far.  Over the next two days, we’ll hear from speakers from across...   Read More

Direct-to-consumer advertising makes doctors and patients stronger partners

By Josephine Martin  |    December 2, 2015
The New York Times’ editorial board is right when it notes that direct-to-consumer (DTC) pharmaceutical advertising helps “educate and inform patients about drugs their doctors might not mention,...   Read More

2015 Guiding Principle: Building on Our 2014 Focus on Patients

By Josephine Martin  |    January 9, 2015
Throughout 2014, I’ve seen firsthand the impact that the biopharmaceutical sector has on patients and the health care system every day. The innovative spirit, passion for helping patients,...   Read More

Responsible Clinical Trial Data Sharing Is Enhancing Science and Improving Patient Health

By Josephine Martin  |    November 14, 2014
The discovery and development of new medicines for patients is a comprehensive, data-driven process that requires years of research. At the heart of this endeavor is the clinical trial, the rigorous...   Read More

What 60 Minutes Missed on the Value and Cost of Cancer Medicines

By Josephine Martin  |    October 5, 2014
The biopharmaceutical industry is proud of its track record of developing innovative medicines that have extended and improved the lives of patients suffering from cancer.   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates